Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors
TORC1/2抑制剂(TAK-228)与Aurora A激酶抑制剂(Alisertib)联合治疗实体瘤的临床前和剂量探索I期试验结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-3498
Davis, S Lindsey; Ionkina, Anastasia A; Bagby, Stacey M; Orth, James D; Gittleman, Brian; Marcus, Joshua M; Lam, Elaine T; Corr, Bradley R; O'Bryant, Cindy L; Glode, Ashley E; Tan, Aik-Choon; Kim, Jihye; Tentler, John J; Capasso, Anna; Lopez, Kyrie L; Gustafson, Daniel L; Messersmith, Wells A; Leong, Stephen; Eckhardt, S Gail; Pitts, Todd M; Diamond, Jennifer R